Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancer
Status:
Completed
Trial end date:
2020-10-10
Target enrollment:
Participant gender:
Summary
ABIFOOD study is a randomized open-labelled, phase I study to evaluate food effect in the
pharmacokinetic parameters of abiraterone acetate (AA) at reduced doses, versus AA in fasting
conditions at conventional doses, in castration resistant prostate cancer (mCRPC) patients
who have progressed to docetaxel.
Phase:
Phase 1
Details
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla